SynCore Biotechnology Co Ltd
TPEX:4192
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
SynCore Biotechnology Co Ltd
TPEX:4192
|
TW |
|
V
|
Viemed Healthcare Inc
F:VIJ
|
US |
|
H
|
Hsinjing Holding Co Ltd
TPEX:3713
|
TW |
|
C
|
Centaurus Energy Inc
F:72M
|
CA |
Shareholder Yield
Current shareholder yield for SynCore Biotechnology Co Ltd is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
SynCore Biotechnology Co Ltd
| Average Annual Return | -34.26% |
| Standard Deviation of Annual Returns | 30.63% |
| Max Drawdown | -96% |
| Market Capitalization | 685.7m TWD |
| Shares Outstanding | 35 160 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
SynCore Biotechnology Co Ltd's latest stock split occurred on Jun 29, 2023
The company executed a 267-for-1000 stock split, meaning that for every 1000 shares held, investors received 267 new shares.
Before the split, SynCore Biotechnology Co Ltd traded at 17.5226 per share. Afterward, the share price was about 65.5874.
The adjusted shares began trading on Jun 29, 2023. This was the only stock split in SynCore Biotechnology Co Ltd's history.
